ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Tuesday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Performance

ObsEva has a fifty-two week low of $0.08 and a fifty-two week high of $2.14. The firm has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. The stock’s fifty day moving average is $0.01.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.